These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 22532037)

  • 21. Regional citrate anticoagulation using a citrate-based substitution solution for continuous venovenous hemofiltration in cardiac surgery patients.
    Thoenen M; Schmid ER; Binswanger U; Schuepbach R; Aerne D; Schmidlin D
    Wien Klin Wochenschr; 2002 Feb; 114(3):108-14. PubMed ID: 12060967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Citrate anticoagulation during plasma exchange in a patient with thrombotic thrombocytopenic purpura: short heparin-free hemodialysis helps to attenuate citrate load.
    Buturović-Ponikvar J; Pernat AM; Ponikvar R
    Ther Apher Dial; 2005 Jun; 9(3):258-61. PubMed ID: 15967002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exclusive use of acid citrate dextrose for anticoagulation during extracorporeal photopheresis in patients with contraindications to heparin: an effective protocol.
    Nedelcu E; Ziman A; Fernando LP; Cook K; Bumerts P; Schiller G
    J Clin Apher; 2008; 23(2):66-73. PubMed ID: 18286495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Citrate anticoagulation using ACD solution A during long-term haemodialysis.
    Wright S; Steinwandel U; Ferrari P
    Nephrology (Carlton); 2011 May; 16(4):396-402. PubMed ID: 21054668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of low-dose citrate anticoagulation on the clinical safety and efficacy of direct adsorption of lipoproteins (DALI apheresis) in hypercholesterolemic patients: a prospective controlled clinical trial.
    Bosch T; Heinemann O; Duhr C; Wendler T; Keller C; Fink E; Kirschner T; Klebert S; Samtleben W
    Artif Organs; 2000 Oct; 24(10):790-6. PubMed ID: 11091168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional anticoagulation with acid citrate dextrose-A for extracorporeal photoimmunochemotherapy.
    Apsner R; Uenver B; Sunder-Plassmann G; Knobler RM
    Vox Sang; 2002 Oct; 83(3):222-6. PubMed ID: 12366763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bench-to-bedside review: Citrate for continuous renal replacement therapy, from science to practice.
    Oudemans-van Straaten HM; Ostermann M
    Crit Care; 2012 Dec; 16(6):249. PubMed ID: 23216871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Citrate anticoagulation for continuous venovenous hemofiltration.
    Oudemans-van Straaten HM; Bosman RJ; Koopmans M; van der Voort PH; Wester JP; van der Spoel JI; Dijksman LM; Zandstra DF
    Crit Care Med; 2009 Feb; 37(2):545-52. PubMed ID: 19114912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: single-center experience.
    Morgera S; Scholle C; Voss G; Haase M; Vargas-Hein O; Krausch D; Melzer C; Rosseau S; Zuckermann-Becker H; Neumayer HH
    Nephron Clin Pract; 2004; 97(4):c131-6. PubMed ID: 15331942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in continuous renal replacement therapy: citrate anticoagulation update.
    Tolwani A; Wille KM
    Blood Purif; 2012; 34(2):88-93. PubMed ID: 23095407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Citrate anticoagulation during continuous renal replacement therapy in pediatric critical care.
    Davis TK; Neumayr T; Geile K; Doctor A; Hmeil P
    Pediatr Crit Care Med; 2014 Jun; 15(5):471-85. PubMed ID: 24777299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complications of donor apheresis.
    Winters JL
    J Clin Apher; 2006 Jul; 21(2):132-41. PubMed ID: 15880355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inpatient citrate-based hemodialysis in pediatric patients.
    Fajardo C; Sanchez CP; Cutler D; Sahney S; Sheth R
    Pediatr Nephrol; 2016 Oct; 31(10):1667-72. PubMed ID: 27167382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Membrane therapeutic plasma exchange with and without heparin anticoagulation.
    Brunetta Gavranić B; Bašić-Jukić N; Premužić V; Kes P
    J Clin Apher; 2017 Dec; 32(6):479-485. PubMed ID: 28485027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DALI LDL-apheresis: anticoagulation with r-hirudin in a patient with heparin-induced thrombocytopenia (HIT II).
    Thomas HP; Kassner U; Schliesser C; Steinhagen-Thiessen E
    Int J Artif Organs; 2000 Sep; 23(9):637-41. PubMed ID: 11059887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unexpected citrate toxicity and severe hypocalcemia during apheresis.
    Uhl L; Maillet S; King S; Kruskall MS
    Transfusion; 1997 Oct; 37(10):1063-5. PubMed ID: 9354826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs.
    Bai M; Zhou M; He L; Ma F; Li Y; Yu Y; Wang P; Li L; Jing R; Zhao L; Sun S
    Intensive Care Med; 2015 Dec; 41(12):2098-110. PubMed ID: 26482411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin anticoagulation versus regional citrate anticoagulation for membrane therapeutic plasma exchange in patients with increased bleeding risk.
    Jiao J; Yu Y; Wei S; Tian X; Yang X; Feng S; Li Y; Sun S; Zhang P; Bai M
    Ren Fail; 2023 Dec; 45(1):2210691. PubMed ID: 37183868
    [No Abstract]   [Full Text] [Related]  

  • 39. Renal replacement therapy and anticoagulation.
    Brandenburger T; Dimski T; Slowinski T; Kindgen-Milles D
    Best Pract Res Clin Anaesthesiol; 2017 Sep; 31(3):387-401. PubMed ID: 29248145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new prescription model for regional citrate anticoagulation in therapeutic plasma exchanges.
    Kissling S; Legallais C; Pruijm M; Teta D; Vogt B; Burnier M; Rondeau E; Ridel C
    BMC Nephrol; 2017 Mar; 18(1):81. PubMed ID: 28249613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.